Pharmacoeconomic analyses a tool in private-payer decision-making process
A recent Telus Health comparison of a drug’s cost effectiveness when calculated from the private versus the public-payer perspective demonstrated clearly that the private-payer perspective…
- By: Suzanne Lepage
- January 15, 2021 April 14, 2021
- 08:56












